Other

OCI Reclassification for Sale of Securities, Before Tax

Humana OCI Reclassification for Sale of Securities, Before Tax decreased by 97.7% to $1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from $2.00M to $1.00M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 29, 2026
Metric ID: pfe_oci_reclassification_sale_of_securities_before_tax

Historical Data

12 periods
 Q3 '21Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$16.00M-$50.00M-$61.00M$8.00M-$3.00M$1.00M-$1.00M$10.00M$2.00M$5.00M$44.00M$1.00M
QoQ Change-412.5%-22.0%+113.1%-137.5%+133.3%-200.0%>999%-80.0%+150.0%+780.0%-97.7%
YoY Change-412.5%+94.0%+101.6%-112.5%+433.3%+100.0%+600.0%+340.0%-50.0%
Range-$61.00M$44.00M
CAGR-63.5%
Avg YoY Growth+121.6%
Median YoY Growth+100.0%

Frequently Asked Questions

What is Humana's oci reclassification for sale of securities, before tax?
Humana (HUM) reported oci reclassification for sale of securities, before tax of $1.00M in Q1 2026.
How has Humana's oci reclassification for sale of securities, before tax changed year-over-year?
Humana's oci reclassification for sale of securities, before tax decreased by 50.0% year-over-year, from $2.00M to $1.00M.